Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.
Business Model:
Revenue: $517.2M
Employees: 1,001-5,000
Address: Generaal De Wittelaan L11 A3
City: Mechelen
State: other
Zip: 2800
Country: BE
Galapagos is a Belgium-based biotechnology company that discovers, develops and commercializes small molecule medicines to the treatment of inflammatory and fibrotic diseases.
Contact Phone:
+13215342900
Contact Email:
Listed Exchange:
Other
IPO Date:
10/5/2017
Ticker Symbol:
GLPG
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Name | Price |
---|---|---|
6/2022 | CellPoint | |
6/2021 | Abound Bio | |
1/2013 | Cangenix | |
2/2010 | Argenta Discovery | |
1/2007 | ProStrakan | |
12/2006 | Inpharmatica | |
9/2005 | BioFocus DPI |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|